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Abstract
Background: Eight genotypes of Hepatitis B virus designated A-H, have been known but in
Pakistan, no such data is available on the prevalent HBV genotypes. Therefore, the subject study
was conducted to determine HBV genotypes in the indigenous Pakistani population.
Methods: A total of 690 individuals were enrolled for HBV screening with EIA and nested PCR.
Positive samples were further analyzed to determine HBV genotypes (A-F) by multiplex-PCR using
type specific primers.
Results: 110 (15.94%) individuals were positive for HBV, including 64% males and 36% females.
Out of these, 66 samples (65.34%) were classified into genotype D, 27 (26.73%) were of genotype
B while 5(4.95%) had genotype A. In 3 (2.98%) samples, multiple genotypes were detected
(genotype A+B; 2(1.99%) and genotypes B+D; 1(0.99%). Nine (8.18%) samples remained untyable.
Conclusion: In Asia, genotypes B and C are the most prevalent but our study reveals that
genotype D is predominant and HBV infection constitutes a significant health problem in Pakistan.
Background
Hepatitis B virus (HBV) infection is a well recognized and
major health problem leading to significant morbidity
and mortality worldwide especially in the developing
countries. Approximately, 2 billion people in the world
have been infected by HBV [1], 400 million of who are
chronic carriers [2]. The virus causes acute hepatitis of var-
ying severity [3] and persists in 95% of children and 2–
10% of adult patients [4] leading to chronic liver disease,
cirrhosis, hepatocellular carcinoma [5] and even fulmi-
nant hepatitis [6]. In Pakistan, HBV infection rate is
increasing day by day. The reason may be the lack of
proper health facilities or poor economical status and less
public awareness about the transmission of major com-
municable diseases like Hepatitis B virus, Hepatitis C virus
and Human Immunodeficiency Virus.
Hepatitis B virus exhibits genetic variability with an esti-
mated rate of 1.4 – 3.2 × 10-5 nucleotide substitution per
site per year [7] which resulted in well recognized sub-
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types of the virus. In addition, virus variants arise during
replication as a result of nucleotide misincorporations in
the absence of any proof reading capacity by the viral
polymerase. HBV has been classified into 8 well defined
genotypes on the basis of an inter-group divergence of 8%
or more in the complete genomic sequence, each having
distinct geographical distribution. Genotype A can be
regarded as pandemic but is most commonly found in
Northern Europe, North America and Central Africa,
while genotype B predominates in Asia (China, Indonesia
and Vietnam). Genotype C is found in the Far East in
Korea, China, Japan and Vietnam as well as the Pacific rim
and Island Countries, while genotype D, which is also
more or less pandemic, is found in the Mediterranean
countries, the Middle East extending to India, North
America and parts of the Asia-Pacific region. Genotype E
is related to Africa while genotype F is found predomi-
nately in South America, including among Amerindian
populations, and also Polynesia. Genotype G has been
found in North America and Europe while the most
recently identified genotype H has been reported from
America [8].
Since the discovery of HBV subtypes, their impact on the
natural course of infection has been studied mainly in the
South-East Asia where HBV is hyper endemic with prevail-
ing genotypes B and C. The clinical significance of differ-
ent HBV genotypes has become increasingly recognized in
patients with acute and chronic infection. The course of
HBV infection depends on several factors such as host
genetic factors, age and genetic variability of the virus
[9,10]. Genotype C induces a more severe disease, has
higher scores for fibrosis and is more prevalent in cirrhotic
patients as compared to genotype B [11]. Seroconversion
from HBeAg to anti-HBeAg positivity occurs much earlier
in genotype B than genotype C carriers [12]. Genotype C
is found to have lower HBV DNA level than genotype A, B
and D in the HBeAg positive patients [13]. Taken together,
these studies suggest well established pathogenic, epide-
miological, clinical and therapeutic differences among
HBV genotypes. However, the epidemiology of mixed
HBV genotype infections is very less understood [14].
In the present study, the molecular investigation of HBV
genotypes was determined as there is no such data availa-
ble in Pakistan. The infection markers were compared
with patients' age; gender their clinical and molecular data
to find out the possible correlation.
Methods
Individuals are regularly screened for HBV infection at
National Institute of Health (N.I.H) Islamabad which are
referred from various hospitals and medical centers of the
country. Subjects for the present study were selected ran-
domly from the major and prestigious hospitals of each of
the four provinces of the country. These hospitals also rep-
resent as a reference centre for the disease investigation.
Because the current project is based on the reporting of
HBV genotypes for the first time, therefore, no certain cri-
teria like risk groups, age, gender was considered, how-
ever, samples positive for HCV and HDV were excluded
from the study criteria.
A total of 690 individuals were included after approval
from Research Committee of the Institute. Informed con-
sent was obtained from all the individuals involved.
Serum HBsAg was assayed by Abbott-IMX HBsAg V2
Assay. DNA was extracted from 100 µl serum sample of
110 HBsAg positive patients using Biospin Blood
Genomic DNA Mini-Prep Kit (Bioer Technology Co., Ger-
many) according to the manufacturer's protocol, eluted in
70 µl buffer and stored at -20°C. Genotyping was per-
formed using methodology as reported by Naito et al.,
2001 [15]. 50 µl reaction mixture was used containing 1×
buffer, 20 µM primers, 2.4 µM dNTPs and 1.5 U Taq
polymerase. 40 cycles was performed at 95°C for 1 min,
50°C for 30 sec, 72°C for 30 sec. The amplified product
was run on 2.5% agarose gel and visualized under UV illu-
minator.
Data was analyzed using Epi-Info 6.0 [16]. A p value of
less than or equal to 0.05 was considered as significant.
Results
690 individuals were screened for the detection of hepati-
tis B surface antigen and HBV DNA. 110 (15.94%) were
found positive for both infection markers [IMX HBsAg V2
Assay (EIA 3.0) and PCR]. Males were found to be more
frequently infected as compared to females with a positiv-
ity ratio of 2.23: 1 respectively. Very young females of less
than 20 years of age were not found to be positive for hep-
atitis surface antigen. 58 individuals positive for surface
antigen were belonging to the age group ranging 21–40
years of age followed by the 39 positive individuals of 41–
60 years age. Highest frequency of HBsAg positive males
were found in the younger age with more than positive
individuals falling under this 21–40 age group while very
young and very old individuals were very less frequently
infected by HBV. Majority of the females found to be
infected with hepatitis B virus were aged more than 40
years. Infection was not found in very young females
while only 3 were positive from post 60 years age (Table
1, 2).
Out of the total 110 samples analyzed, 101 (91.81%)
showed genotype specific bands while the remaining 9
HBV positive samples (8.19%) were found negative. 66
samples (65.34%) were classified into genotype D, 27
(26.73%) were of genotype B while 5(4.95%) had geno-BMC Infectious Diseases 2007, 7:115 http://www.biomedcentral.com/1471-2334/7/115
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type A. In 3 (2.98%) samples, mix genotypes were
detected as: [genotype A+D; 2(1.99%) and genotypes
B+D; 1(0.99%)].
The prevalence of genotypes was assessed further with
respect to patient's age (Table 3). There was no trend
found in the distribution of genotypes among various age
groups. However, genotype A was absent from individuals
aged more than 60 years. Genotype B and D were present
in all age groups while the patients infected with multiple
genotypes were all belonging to age group between 41–60
years. This relationship was, however, found non signifi-
cant (p = 0.142).
The results of alanine aminotransferase level testing were
compared among the individuals infected with different
genotypes. There was no significant relationship found
among individuals however, the highest ALT level (86.53
± 20.67) was found in the individuals infected with more
than one genotype. It was found that genotype A and gen-
otype D positive individuals showed two fold increase in
ALT level with 73.25 ± 31.23 U/L and 69.88 ± 33.12 U/L
respectively. The ALT level of genotype A infected individ-
uals was the lowest of all other patients with mean value
of 53.67 ± 19.87 U/L (Figure 1).
Discussion
Hepatitis B virus (HBV) infection is a global health prob-
lem with its continuously increasing burden in the devel-
oping countries like Pakistan. About 400 million people
of the world population are chronic carriers of the virus
[17]. In addition to serological classification of HBV iso-
lates into nine subtypes on the basis of HBsAg determi-
nants [18], a genetic classification based on the
comparison of complete genomes has defined 8 geno-
types of HBV (A to H). To investigate the epidemiological
distribution of HBV genotypes in our local population, we
applied a multiplex PCR based methodology. Although
the most common method for HBV genotyping is by PCR-
RFLP technique, but it is reported that HBV genotyping by
multiplex PCR is more sensitive than genotyping system
using RFLP analysis. Leblebicioglu reported that nested
PCR methodology for HBV genotyping is 1000-fold more
sensitive than PCR-RFLP [19]. Lim also deduced that HBV
genotyping method using nested PCR with type specific
primers is more sensitive than PCR-RFLP [20].
Total screening of 690 individuals resulted in 110 infected
patients with hepatitis B virus representing 15.94% of the
total subjects. This represents quite a higher number of
infected individuals. According to WHO, Pakistan falls
under the endemic region with 3% HBV infected country
Table 3: Origin based distribution of Hepatitis B virus genotypes 
among Hepatitis B virus infected individuals belonging to various 
age groups
Number of Individuals
Origin Age 
Group
Genotype A Genotype B Genotype D
Punjab (30)
1–20 x 2 x
21–40 2 4 11
41–60 x 3 8
>60 x x x
Sindh (25)
1–20 x 1 x
21–40 1 1 6
41–60 1 x 12
>60 x 2 1
Balouchistan 
(18)
1–20 1 1 1
21–40 x 1 5
41–60 x 2 3
>60 x x 4
NWFP (28)
1–20 x x x
21–40 x 4 8
41–60* x 4 6
>60 x 2 1
Total 5 27 66
* represents the age group to which belong the three individuals 
infected with multiple HBV genotypes.
Table 2: Geographical distribution of patients infected with 
Hepatitis B virus belonging to all the four provinces of the 
country
Origin Number of patients HBsAg +ve
Punjab 330 39
Sindh 105 25
Balouchistan 99 18
NWFP 156 28
Total 690 110
Table 1: Age and Gender wise distribution of patients positive for 
Hepatitis B virus
Age 
(years)
HBV 
positive 
Total
HBV + 
Male
HBV +ve 
Female
Mean ALT 
(U/L)
1–20 06 06 0 275.5 ± 181.4
21–40 55 41 14 65.21 ± 35.33
41–60 39 22 17 57.54 ± 22.76
> 6 0 1 00 70 3 5 9 . 8 5  ±  1 9 . 6 5
Total 110 76 34
Mean ALT (U/L) is also shown.BMC Infectious Diseases 2007, 7:115 http://www.biomedcentral.com/1471-2334/7/115
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population. Different studies have been conducted in the
country to assess the disease burden in the indigenous
population. All such studies present a varying rate of
infection based on the study design, population selected,
diagnostic assays and demographical and epidemiologi-
cal variation. According to various study groups, the HBV
prevalence rate has been reported as 2–10% among
healthy blood donors; 5–9% among health care person-
nel; 3.6–18.66% among the general population; 3.16%
among the pregnant women; 10–20% in patients with
provisional diagnosis of hepatitis and 3.16–10.4% among
professional blood donors [21]. We have found 15.94%
infected population out of the study subjects because
almost all of the individuals included in the current study
were clinically infected patients who were referred to hos-
pitals and medical centers for their medication and physi-
cians advise. This figure, however, does not represent the
overall picture of the total country's population preva-
lence rate infected with hepatitis B virus.
The current study reveals that males are more frequently
positive for HBV infection as compared to females. The
prevalence of HBV infection was found to be higher in
males (69.1%) than females (30.9%). Also, HBV infection
is found to be significantly higher in persons with age
between 21–40 years. Leung also reported that men aged
40 years or old were most affected HBV patients as com-
pared to females [22]. The reason may be that the men are
more exposed to the risk factors. In Pakistan, males are
more educated and employed working outsides their
homes or in agricultural lands while women are mostly
involved in house activities based on the cultural and reli-
gious preferences and influences. Therefore, it is well
understood to analyze the difference of frequency of infec-
tion among the gender category. Males are more com-
monly involved in the trends and practices leading to the
transmission of infections like blood transfusions and
barber visiting so becoming more prone to get the infec-
tion at a much frequent rate as compared to females. The
vertical transmission of HBV infection in Pakistan has
been reported to be very low rendering the horizontal
transmission a major risk factor for the infection acquisi-
tion. It has already been documented that the HBsAg prev-
alence rate in pregnant women was 2.5% in Pakistan, out
of which 17% and 61% were HBeAg and anti-HBeAg pos-
itive thus indicating the vertical transmission a less impor-
tant cause of HBV transmission [23].
The 110 samples analyzed for genotyping indicated the
highest prevalence of genotype D followed by genotype B,
A and co-infection with multiple genotypes including
HBV/A+D and HBV/B+D. Genotypes C, E and F were not
found in any patient indicating absence of these strains in
this region. Apart from Pakistan, the initial studies on
HBV genotyping in the other regions of Asia revealed that
genotypes B and C are the most prevalent genotypes in
this region. It was because of the fact that all such studies
were reported mostly from Japan and China where geno-
types B and C are the most prevalent. Later on, it was
found that all the seven HBV genotypes can be found in
Asia [24]. For instance, the predominant genotypes in
India are Genotype A and D [25]; the predominant HBV
genotype in Afghanistan was found to be genotype D [26].
The epidemiological data about HBV genotypes in various
Asian countries revealed the presence of all seven geno-
types in Asia, particularly the pre-dominance of genotype
D.
It is of much important finding that we have reported
such patients infected with multiple (more than one)
HBV genotypes for the first time in Pakistan. This is in
accordance with a number of very recent studies from dif-
ferent regions of the world. Hannoun found 8% of HBV
patients with genotype mixture [27]. Toan found that
Mean ALT (U/L) of patients infected with different genotypes of hepatitis B virus Figure 1
Mean ALT (U/L) of patients infected with different genotypes of hepatitis B virus.
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chronic patients are more prone to be infected with more
than one HBV genotype than acutely infected patients
[19]. Genotypes mixture in HBV patients is also common
in Thailand [28]. 16% HBV cases were positive for HBV
genotype mixture in France [29].
In our study, 9 HBV DNA positive samples remained neg-
ative for HBV genotypes. It may be assumed that such
samples represent recombinant or new genotypic variants
present in our population that can be resolved after
sequencing and further analysis. Because, some minor
HBV genotypes as well as novel or distinct genotypic
groups may be present in any population besides major
genotypes [30].
Conclusion
HBV genotypes influence the severity of liver disease and
response to interferon and antiviral therapy. These are
also expected to influence the emergence of resistant.
Patients infected with HBV of certain genotypes can be
directed to the other therapeutic options to spare the cost
and burden of treatment [31]. Therefore, the appropriate
and definite knowledge of all the HBV genotypes preva-
lent in a certain region is of immense importance for the
proper and effective management of HBV patients.
As we have reported for the first time the prevalence of
HBV genotype D as the pre-dominant genotype in Paki-
stan and also the patients infected with more than one
HBV genotypes, therefore, it is of worth important consid-
eration for clinicians to adopt better strategies for appro-
priate prevention and cure of infection. Furthermore, such
studies are important for epidemiological reasons as well
as developing effective therapeutic management against
such infections.
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